Publicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (32)

2023

  1. A 3-Year Retrospective Study of the Impact of Integrating an Addiction Liaison Team into an Outpatient Alcoholism Treatment Programme

    Alcohol and Alcoholism, Vol. 58, Núm. 5, pp. 515-522

2022

  1. Brain oscillatory functioning after long-term alcohol abstinence

    International Journal of Psychophysiology, Vol. 177, pp. 240-248

  2. Molecular Alterations of the Endocannabinoid System in Psychiatric Disorders

    International Journal of Molecular Sciences, Vol. 23, Núm. 9

  3. Neuropsychological Symptom Identification and Classification in the Hospitalized COVID-19 Patients During the First Wave of the Pandemic in a Front-Line Spanish Tertiary Hospital

    Frontiers in Psychiatry, Vol. 13

  4. Sex Differences in Plasma Lysophosphatidic Acid Species in Patients with Alcohol and Cocaine Use Disorders

    Brain Sciences, Vol. 12, Núm. 5

2021

  1. COVID-19-Related Neuropsychiatric Symptoms in Patients With Alcohol Abuse Conditions During the SARS-CoV-2 Pandemic: A Retrospective Cohort Study Using Real World Data From Electronic Health Records of a Tertiary Hospital

    Frontiers in Neurology, Vol. 12

  2. Metabolomic connections between schizophrenia, antipsychotic drugs and metabolic syndrome: A variety of players

    Current Pharmaceutical Design, Vol. 27, Núm. 39, pp. 4049-4061

  3. Plasma concentrations of lysophosphatidic acid and autotaxin in abstinent patients with alcohol use disorder and comorbid liver disease

    Biomedicines, Vol. 9, Núm. 9

2020

  1. Abstinent patients with alcohol use disorders show an altered plasma cytokine profile: Identification of both interleukin 6 and interleukin 17A as potential biomarkers of consumption and comorbid liver and pancreatic diseases

    Journal of Psychopharmacology, Vol. 34, Núm. 11, pp. 1250-1260

  2. Effects of including mutual aid groups in the adherence of a continuing care programme of alcohol dependent patients carried out in a Primary Care setting

    Atencion Primaria, Vol. 52, Núm. 8, pp. 555-562

  3. Endocannabinoid System Components as Potential Biomarkers in Psychiatry

    Frontiers in Psychiatry, Vol. 11

  4. Plasma tryptophan and kynurenine pathway metabolites in abstinent patients with alcohol use disorder and high prevalence of psychiatric comorbidity

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 102

  5. Psychophysiological Correlates of Emotional- And Alcohol-Related Cues Processing in Offspring of Alcohol-Dependent Patients

    Alcohol and Alcoholism, Vol. 55, Núm. 4, pp. 374-381

  6. Stop! – The automatic tendency of action, inhibition and frontal activation in individuals with alcohol-use disorder in abstinence

    International Journal of Psychophysiology, Vol. 158, pp. 123-135

2019

  1. Drug using risks screening in primary care patients using the ASSIST test: Cross sectional study

    Atencion Primaria, Vol. 51, Núm. 4, pp. 200-207

  2. Retinal nerve fiber layer in patients with alcohol use disorder

    Applied Sciences (Switzerland), Vol. 9, Núm. 24

2018

  1. A bibliometric analysis of scientific production on second-generation anti-psychotic drugs in Malaysia

    Malaysian Journal of Medical Sciences, Vol. 25, Núm. 3, pp. 40-55

  2. P3 Component as a Potential Endophenotype for Control Inhibition in Offspring of Alcoholics

    Alcohol and Alcoholism, Vol. 53, Núm. 6, pp. 699-706

2017

  1. Evaluación de la capacidad de inhibición en dependientes de alcohol: traducción de la tarea de la señal de stop modificada

    Actas Espanolas de Psiquiatria, Vol. 45, Núm. 1, pp. 21-31

  2. Plasma chemokines in patients with alcohol use disorders: Association of CCL11 (Eotaxin-1) with psychiatric comorbidity

    Frontiers in Psychiatry, Vol. 7, Núm. JAN